John A. Hall
15Patents
6h-index
26Co-inventors
66Inventor score
Filing activity: May 26, 1994 → Mar 8, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5942234A | Hepatitis C virus asialoglycoproteins | Emerging Cross-Sectional Technologies | 40 | Expired |
| US6074846A | Hepatitis C virus asialoglycoproteins | Emerging Cross-Sectional Technologies | 32 | Expired |
| US6274148A | Hepatitis C virus asialoglycoproteins | Emerging Cross-Sectional Technologies | 27 | Expired |
| US6074852A | Hepatitis C virus asialoglycoproteins | Emerging Cross-Sectional Technologies | 25 | Expired |
| US7105303B2 | Antibodies to hepatitis C virus asialoglycoproteins | Emerging Cross-Sectional Technologies | 25 | Expired |
| US6465231B2 | GSK3 polypeptides | Physics | 12 | Expired |
| US6716624B2 | GSK3 polypeptides | Physics | 2 | Expired |
| US7135321B2 | GSK3 polypeptides | Physics | 0 | Expired |
| US11746140B2 | Composition comprising recombinant GPlbα receptor protein | Physics | 0 | Active |
| US11708418B2 | Compositions, methods and/or kits comprising a recombinant human CD38- extracellular domain | Chemistry; Metallurgy | 0 | Active |
| US10753939B2 | HCV NS4a/modified NS3 polypeptides and uses thereof | Physics | 0 | Active |
| US10267803B2 | HCV NS4A/modified NS3 polypeptides and uses thereof | Physics | 0 | Active |
| US7807430B2 | GSK3 polypeptides | Physics | 0 | Active |
| US7361484B2 | GSK3 polypeptides | Physics | 0 | Active |
| US7195886B2 | GSK3 polypeptides | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.